ArticleIBRO neuroscience reports2026
miR-125a-5p inhibits NF-κB by negatively regulating TRAF2 to alleviate inflammatory injury in ischemic stroke rats.
Article in IBRO neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The expression of certain miRNAs are significantly associated with both inflammatory and ischemia-reperfusion (I/R) injury in ischemic stroke. In this study, we identified cerebral cortex miR-125a-5p via RNA sequencing, which showed significant enrichment in inflammatory pathways. Cerebral infarction volume and neurological deficits were evaluated using TTC staining, mNSS scoring, and the open field test. Nissl staining and TUNEL assays were used to assess cortical apoptosis. TRAF2, NIK, and p-NFκB levels in the cerebral cortex, as well as serum TNF-α, IL-1β, and IFN-γ concentrations, were measured by Western blot and ELISA. We found that TRAF2, a predicted target of miR-125a-5p, is linked to NF-κB pathway. Overexpression of miR-125a-5p reduced infarct volume, inhibited apoptosis and neurological deficits, and downregulate TRAF2, NIK and p-NF-κB in the cortex, along with TNF-α, IL-1β, and INF-γ in the serum of I/R rats. The miR-125a-5p negatively regulates TRAF2, alleviating inflammation-induced I/R injury by modulating the NF-κB pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.